🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Waldenström's Macroglobulinemia (lymphoplasmacytic lymphoma, WM) remains in...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2006-09
Trial ID
NCT00422656
Treatments Being Tested
This is a 26 week randomized controlled study. The study consists of, in or...
Status
Completed
Location
VA WNY Healthcare System
Start Date
2010-09
Trial ID
NCT01186822
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
The purpose of this clinical trial is to learn if intervention on health be...
Status
Completed
Location
Azienda Ospedaliera Universitaria Renato Dulbecco
Start Date
2023-11-07
Trial ID
NCT06131411
Treatments Being Tested
The aim of this study is to determine feasibility of a randomized controlle...
Status
Recruiting
Location
Cape Fear Valley Medical Center
Start Date
2024-08-01
Trial ID
NCT06495632
Treatments Being Tested
The purpose of this study is to compare the effects of two different anti-H...
Status
Completed
Location
UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS
Start Date
2002-01
Trial ID
NCT00385632
Treatments Being Tested
Comparison of the safety and effectiveness of standard drug dosing versus a...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00250432
Treatments Being Tested
This is a single cohort observational safety study. All patients will be tr...
Status
Completed
Location
Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Start Date
2007-08-30
Trial ID
NCT01152606
Treatments Being Tested
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
To determine the recommended Phase IIa dose (RP2D) of the triplet combinati...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2024-12-31
Trial ID
NCT06683755
Treatments Being Tested